COPENHAGEN, Denmark – On March 4, 2025, the World Health Organization (WHO) and the Swiss Confederation officially codified their commitment to future-oriented public health leadership, signing a renewed Country Cooperation Strategy (CCS) set to guide their collaboration through 2028. This agreement represents more than a bureaucratic renewal; it serves as a cornerstone for international health policy, bridging the technical expertise of the WHO with Switzerland’s unique position as a hub for global health diplomacy and innovation.
The formal signing ceremony, held at the WHO Regional Office for Europe in Copenhagen, saw Dr. Hans Henri P. Kluge, WHO Regional Director for Europe, and Barbara Schedler, Ambassador for Global Health at the Swiss Federal Office of Public Health (FOPH), finalize a roadmap that prioritizes health security, digital transformation, and sustainable financing.
The Evolution of a Strategic Partnership: A Chronology
To understand the weight of the 2024–2028 strategy, one must look back at the precedent set over the last decade. Switzerland’s relationship with the WHO has undergone a significant transformation, moving from a standard member-state dynamic to a pioneering model of high-income cooperation.
- 2013: The Pilot Program: Switzerland made history by becoming the first high-income nation in the WHO European Region to adopt a Country Cooperation Strategy. At the time, such frameworks were traditionally reserved for low- and middle-income countries. This decision signaled Switzerland’s intent to treat its domestic health policy as inextricably linked to global health outcomes.
- 2013–2021: Building the Framework: Over the first eight years, the partnership focused on aligning Swiss public health standards with international benchmarks, while concurrently leveraging Swiss technical capacity to assist WHO initiatives in the European theater.
- 2022: The Strategic Pivot: Following the global disruption of the COVID-19 pandemic, both parties recognized that the 2013 framework was insufficient for the challenges of a post-pandemic world. In 2022, the WHO and Switzerland initiated a comprehensive review process to update their cooperation model to meet modern threats, including climate change, antimicrobial resistance, and pandemic preparedness.
- 2025: Formalization: The current agreement, signed on March 4, 2025, represents the culmination of this two-year consultative process, setting the stage for a four-year implementation cycle.
Supporting Data and Strategic Objectives
The 2024–2028 Cooperation Strategy is not a mere statement of intent; it is a granular policy document that aligns with the WHO’s "European Programme of Work (EPW) 2020–2025: ‘United Action for Better Health’."
Core Focus Areas:
- Health Security and Pandemic Preparedness: Central to the strategy is the refinement of the "Global BioHub" system. This initiative, which has seen significant Swiss investment, facilitates the rapid sharing of pathogens and clinical samples to accelerate the development of vaccines and diagnostic tools.
- Digital Health Integration: Recognizing Switzerland’s prowess in data science and medical technology, the strategy outlines a framework for integrating AI and big-data analytics into surveillance systems across the European region.
- Sustainable Financing: With the WHO seeking to modernize its financing model, the strategy emphasizes predictable, flexible funding—an area where Switzerland remains one of the organization’s most reliable partners.
- Strengthening Health Systems: Despite Switzerland’s high-income status, the strategy acknowledges gaps in mental health services and chronic disease management, areas where the WHO’s technical guidance provides significant value to Swiss domestic policy.
Official Perspectives: Bridging Policy and Practice
The partnership is anchored by a shared vision that public health is a global public good. During the signing ceremony in Copenhagen, both leadership teams emphasized the "two-way street" nature of the collaboration.
The WHO Perspective
Dr. Hans Henri P. Kluge underscored the symbolic and practical importance of the agreement, stating, "Switzerland is not merely a host country for the WHO and numerous other international organizations; it is a proactive architect of global health policy. By renewing this strategy, we are ensuring that the lessons learned from the most challenging health crises of the last decade are institutionalized into a proactive, resilient framework."
The Swiss Perspective
Ambassador Barbara Schedler highlighted the alignment between Swiss domestic priorities and global health needs. "For Switzerland, this cooperation is essential for ensuring that our national health systems remain agile in the face of cross-border threats. Our commitment through 2028 reflects our belief that we cannot achieve national health security in a vacuum. We must invest in the WHO’s capacity to lead, coordinate, and act."
Implications for Global Health Governance
The renewal of this strategy has profound implications for how the international community approaches health diplomacy.
A Model for High-Income Cooperation
By maintaining a dedicated Country Cooperation Strategy, Switzerland serves as a model for other wealthy nations. It challenges the assumption that the WHO is only a provider of assistance to developing nations. Instead, it positions the WHO as a central nervous system for knowledge exchange among all nations, regardless of their GDP.
Strengthening the WHO’s Operational Capacity
The partnership serves to solidify the WHO’s presence in Europe. With the organization’s headquarters in Geneva and the regional office in Copenhagen, Switzerland acts as the administrative and diplomatic anchor for the organization. The 2024–2028 strategy ensures that the operational support provided by the Swiss government remains robust, particularly in the realm of biosafety and data-driven public health intelligence.
Response to Emerging Threats
The inclusion of the "Global BioHub" in the strategy is a direct response to the delays experienced in the early stages of the COVID-19 pandemic. By formalizing this, Switzerland and the WHO are signaling that they intend to lead on "pathogen diplomacy"—the ability to transparently share biological data to prevent the next pandemic before it crosses borders.
Conclusion: Looking Ahead to 2028
As the world faces an increasingly complex landscape of health challenges—from the looming threat of climate-driven infectious diseases to the ethical integration of AI in healthcare—the partnership between the WHO and Switzerland acts as a stabilizing force.
The 2024–2028 strategy is not just a document of convenience; it is a strategic commitment to multilateralism. By fostering this deep integration, both parties are effectively hedging against the risks of isolationism in health policy. The years ahead will serve as a test for this renewed commitment, as the global community watches to see how effectively this model can translate high-level policy into tangible health outcomes for the citizens of the European region and beyond.
For those interested in the granular details of this partnership, the full text of the WHO–Switzerland Country Cooperation Strategy 2024–2028 is available through the official WHO/Europe archives. This document will undoubtedly serve as a blueprint for other nations seeking to harmonize their national health agendas with the broader, collective mission of the World Health Organization.
For further information regarding the WHO-Switzerland partnership, including updates on the Global BioHub system, please visit the official WHO/Europe website or contact the WHO Media Team.
About the Author
